Showing results (41-50 of 98) with videos related to
Sort By:
Pageof 10
Oncogene|February 19, 2002
Downregulating PKC delta provides a PI3K/Akt-independent survival signal that overcomes apoptotic signals generated by c-Src overexpressionMinghao Zhong, Zhimin Lu, David A FosterBiochemical and Biophysical Research Communications|May 5, 2010
Phospholipase D stabilizes HDM2 through an mTORC2/SGK1 pathwayDonggon Lyo, Limei Xu, David A FosterCell Cycle (Georgetown, Tex.)|July 28, 2020
Albumin promotes the progression of fibroblasts through late G1 into S-phase in the absence of growth factorsSharmeen Uddin, Nataliya Melnyk, David A FosterBiochemical and Biophysical Research Communications|June 11, 2002
Phospholipase D2 stimulates cell protrusion in v-Src-transformed cellsYingjie Shen, Yang Zheng, David A FosterOncogene|June 19, 2003
Phospholipase D confers rapamycin resistance in human breast cancer cellsYuhong Chen, Yang Zheng, David A FosterOncology Letters|June 20, 2014
BxPC3 pancreatic cancer cells express a truncated Smad4 protein upon PI3K and mTOR inhibitionOnica Legendre, Ayisha Sookdeo, David A FosterOncogene|December 8, 2004
Alternative phospholipase D/mTOR survival signal in human breast cancer cellsYuhong Chen, Vanessa Rodrik, David A FosterMolecular & Cellular Oncology|September 18, 2015
(-)-Oleocanthal rapidly and selectively induces cancer cell death via lysosomal membrane permeabilizationOnica LeGendre, Paul As Breslin, David A FosterThe Science of the Total Environment|July 16, 2025
Safe-by-design green nanopesticides as a sustainable approach for pest management, plant health, and environmental safetyKerem Tok, Tugba Oztekin, Sude Yilmaz, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 9, 2003
Cost and effectiveness of glycoprotein IIb/IIIa-receptor inhibitors in patients with acute myocardial infarction undergoing percutaneous coronary interventionPatrick L McCollam, David A Foster, Jeffrey S RiesmeyerPageof 10